1. Home
  2. BIAF vs GV Comparison

BIAF vs GV Comparison

Compare BIAF & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • GV
  • Stock Information
  • Founded
  • BIAF 2014
  • GV 2013
  • Country
  • BIAF United States
  • GV Canada
  • Employees
  • BIAF N/A
  • GV N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GV Other Consumer Services
  • Sector
  • BIAF Health Care
  • GV Real Estate
  • Exchange
  • BIAF Nasdaq
  • GV Nasdaq
  • Market Cap
  • BIAF 6.7M
  • GV 6.8M
  • IPO Year
  • BIAF 2022
  • GV 2022
  • Fundamental
  • Price
  • BIAF $1.59
  • GV $1.20
  • Analyst Decision
  • BIAF Hold
  • GV
  • Analyst Count
  • BIAF 1
  • GV 0
  • Target Price
  • BIAF N/A
  • GV N/A
  • AVG Volume (30 Days)
  • BIAF 175.0K
  • GV 101.9K
  • Earning Date
  • BIAF 11-14-2025
  • GV 11-28-2025
  • Dividend Yield
  • BIAF N/A
  • GV N/A
  • EPS Growth
  • BIAF N/A
  • GV N/A
  • EPS
  • BIAF N/A
  • GV N/A
  • Revenue
  • BIAF $6,776,739.00
  • GV $7,773,905.00
  • Revenue This Year
  • BIAF N/A
  • GV N/A
  • Revenue Next Year
  • BIAF $20.04
  • GV N/A
  • P/E Ratio
  • BIAF N/A
  • GV N/A
  • Revenue Growth
  • BIAF N/A
  • GV N/A
  • 52 Week Low
  • BIAF $1.52
  • GV $1.02
  • 52 Week High
  • BIAF $46.53
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 34.93
  • GV 27.99
  • Support Level
  • BIAF $1.91
  • GV $1.27
  • Resistance Level
  • BIAF $2.25
  • GV $1.46
  • Average True Range (ATR)
  • BIAF 0.20
  • GV 0.09
  • MACD
  • BIAF -0.06
  • GV -0.02
  • Stochastic Oscillator
  • BIAF 6.54
  • GV 10.20

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: